Hennepin EMS, HCMC, Minneapolis Fire Dept. using new system to care for patients with sudden cardiac arrest

by Hennepin Healthcare

First major metropolitan departments in Minnesota to adopt ResQCPR System to improve the likelihood of survival 

Every day, sudden cardiac arrest (SCA), the leading cause of death in the United States, takes the lives of over 1,000 men and women.1 Current survival rates are dismal, with fewer than 10% of patients surviving out-of-hospital cardiac arrest in most communities.1 In Minneapolis, the odds for survival may get better very soon.

Hennepin EMS and the Minneapolis Fire Department are among the first EMS operations in the United States to adopt a new medical device combination, the ResQCPR™ System from ZOLL® Medical Corporation, which was shown in a study to improve survival to one year from out-of-hospital, non-traumatic cardiac arrest by 49% when compared to treatment with conventional cardiopulmonary resuscitation (CPR).2

The ResQCPR System, which was approved by the U.S. Food and Drug Administration (FDA) in March of this year, is the first and only CPR device indicated to improve the likelihood of survival in adults who have experienced non-traumatic sudden cardiac arrest.

The ResQCPR System provides intrathoracic pressure regulation (IPR) therapy, which non-invasively improves circulation to vital organs without the use of pharmaceutical or other agents during CPR by enhancing the negative pressure or vacuum in the chest.

“Hennepin EMS along with the Minneapolis Fire Department are dedicated to the citizens of the greater Minneapolis area,” explains HCMC research director and emergency physician Dr. Johanna Moore. “Our adoption of ZOLL’s ResQCPR System is a big step toward improving the odds of survival of cardiac arrest in our community.”

The ResQCPR System is a combination of two medical devices that are used together during CPR: the ResQPUMP® ACD-CPR Device and the ResQPOD® ITD 16. The ResQPUMP is a hand-held pumping device with a suction cup that is placed on the chest during CPR to perform active compression-decompression CPR (ACD-CPR). It is the only CPR device that allows the rescuer to deliver up to 10 kg of lifting force. The ResQPOD ITD 16 is an impedance threshold device (ITD) that prevents the influx of unnecessary air through the open airway during CPR. When used together, these devices create an enhanced vacuum in the chest that improves blood flow to vital organs during states of low blood flow, such as cardiac arrest.

At 10:30am on Thursday, May 4, 2017 Hennepin EMS and the Minneapolis fire Department will offer a demonstration of the device at the City of Minneapolis – Emergency Operations Training Facility located at 25 37th Ave. NE in Fridley.

About Hennepin Emergency Medical Services
Hennepin EMS is an Urban/Suburban 9-1-1 Emergency Medical Services agency that handles approximately 75,000 calls for service each year from the citizens and visitors of Hennepin County, Minnesota.  Hennepin EMS is based at Hennepin County Medical Center in Downtown Minneapolis and serves 14 municipalities within Hennepin County, covering 266 square miles and a population of over 700,000.

 About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group Company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.

[1]American Heart Association

2ResQCPR System Summary of Safety and Effectiveness Data approved by Food & Drug Administration 2015

Copyright © 2016 ZOLL Medical Corporation. All rights reserved. ResQCPR, ResQPOD, ResQPUMP, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation or its affiliates in the United States and other countries. All other trademarks are the property of their respective owners.